These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23800176)

  • 1. MD-2 is involved in the stimulation of matrix metalloproteinase-1 expression by interferon-γ and high glucose in mononuclear cells - a potential role of MD-2 in Toll-like receptor 4-independent signalling.
    Lu Z; Li Y; Samuvel DJ; Jin J; Zhang X; Lopes-Virella MF; Huang Y
    Immunology; 2013 Nov; 140(3):301-13. PubMed ID: 23800176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice.
    Lu Z; Zhang X; Li Y; Jin J; Huang Y
    J Endocrinol; 2013 Jan; 216(1):61-71. PubMed ID: 23060524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of lipopolysaccharide and interferon-gamma in inducing interleukin-8 production in human monocytic THP-1 cells is accompanied by up-regulation of CD14, Toll-like receptor 4, MD-2 and MyD88 expression.
    Tamai R; Sugawara S; Takeuchi O; Akira S; Takada H
    J Endotoxin Res; 2003; 9(3):145-53. PubMed ID: 12831455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High glucose and interferon gamma synergistically stimulate MMP-1 expression in U937 macrophages by increasing transcription factor STAT1 activity.
    Nareika A; Sundararaj KP; Im YB; Game BA; Lopes-Virella MF; Huang Y
    Atherosclerosis; 2009 Feb; 202(2):363-71. PubMed ID: 18586252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes.
    Lu Z; Zhang X; Li Y; Lopes-Virella MF; Huang Y
    Immunobiology; 2015 Nov; 220(11):1246-54. PubMed ID: 26162692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4.
    Stevens CW; Aravind S; Das S; Davis RL
    Br J Pharmacol; 2013 Mar; 168(6):1421-9. PubMed ID: 23083095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2.
    Rallabhandi P; Phillips RL; Boukhvalova MS; Pletneva LM; Shirey KA; Gioannini TL; Weiss JP; Chow JC; Hawkins LD; Vogel SN; Blanco JC
    mBio; 2012; 3(4):. PubMed ID: 22872782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal Integration of IFN-I and IFN-II With TLR4 Involves Sequential Recruitment of STAT1-Complexes and NFκB to Enhance Pro-inflammatory Transcription.
    Piaszyk-Borychowska A; Széles L; Csermely A; Chiang HC; Wesoły J; Lee CK; Nagy L; Bluyssen HAR
    Front Immunol; 2019; 10():1253. PubMed ID: 31231385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
    Sauter KS; Brcic M; Franchini M; Jungi TW
    Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the molecular expression and regulation of toll pathway in HT-29 cells].
    Chen X; Ouyang Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):581-5. PubMed ID: 20848773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key residues that confer Rhodobacter sphaeroides LPS activity at horse TLR4/MD-2.
    Irvine KL; Gangloff M; Walsh CM; Spring DR; Gay NJ; Bryant CE
    PLoS One; 2014; 9(5):e98776. PubMed ID: 24879320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
    Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
    Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid differentiation protein 2 silencing decreases LPS-induced cytokine production and TLR4/MyD88 pathway activity in alveolar macrophages.
    Ren W; Hu L; Hua F; Jin J; Wang Y; Zhu L
    Immunol Lett; 2011 Dec; 141(1):94-101. PubMed ID: 21849156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma-induced MD-2 protein expression and lipopolysaccharide (LPS) responsiveness in corneal epithelial cells is mediated by Janus tyrosine kinase-2 activation and direct binding of STAT1 protein to the MD-2 promoter.
    Roy S; Sun Y; Pearlman E
    J Biol Chem; 2011 Jul; 286(27):23753-62. PubMed ID: 21572044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LPS-induced CXCR7 expression promotes gastric Cancer proliferation and migration via the TLR4/MD-2 pathway.
    Li N; Xu H; Ou Y; Feng Z; Zhang Q; Zhu Q; Cai Z
    Diagn Pathol; 2019 Jan; 14(1):3. PubMed ID: 30636642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem Cell-Induced Inflammation in Cholesteatoma is Inhibited by the TLR4 Antagonist LPS-RS.
    Schürmann M; Greiner JFW; Volland-Thurn V; Oppel F; Kaltschmidt C; Sudhoff H; Kaltschmidt B
    Cells; 2020 Jan; 9(1):. PubMed ID: 31947538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 and high glucose synergistically upregulate MMP-1 expression by U937 mononuclear phagocytes via ERK1/2 and JNK pathways and c-Jun.
    Li Y; Samuvel DJ; Sundararaj KP; Lopes-Virella MF; Huang Y
    J Cell Biochem; 2010 May; 110(1):248-59. PubMed ID: 20225236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells.
    Abreu MT; Arnold ET; Thomas LS; Gonsky R; Zhou Y; Hu B; Arditi M
    J Biol Chem; 2002 Jun; 277(23):20431-7. PubMed ID: 11923281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emodin ameliorated lipopolysaccharide-induced fulminant hepatic failure by blockade of TLR4/MD2 complex expression in D-galactosamine-sensitized mice.
    Yin X; Gong X; Jiang R; Kuang G; Wang B; Zhang L; Xu G; Wan J
    Int Immunopharmacol; 2014 Nov; 23(1):66-72. PubMed ID: 25173984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ergosta-7, 9 (11), 22-trien-3β-ol Interferes with LPS Docking to LBP, CD14, and TLR4/MD-2 Co-Receptors to Attenuate the NF-κB Inflammatory Pathway
    Hsieh WT; Hsu MH; Lin WJ; Xiao YC; Lyu PC; Liu YC; Lin WY; Kuo YH; Chung JG
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.